Christie set to mass produce CounterAct with Care222, the safer, filtered far-UVC disinfection technology for use around people

As we prepare for a post-pandemic world where reducing pathogens and viral spread is essential, global visual technology company Christie® announced the mass production of its Christie® CounterAct™ line of commercial UV disinfection products with patented Care222® far-UVC light technology. CounterAct fixtures are designed for use in occupied indoor spaces, from cinemas, theme parks, museums, and sports complexes, to retail, restaurants, as well as transit hubs at airports, train and subway stations.

Source: Christie set to mass produce CounterAct with Care222, the safer, filtered far-UVC disinfection technology for use around people